IPOPLUS

₹0.58

▼ -0.02 -3.33%

16 Jun 2026

BSE Listed

Shree Ganesh Bio-Tech (Ind (539470)

Volume: 3,36,296Avg Vol 1W: 5,06,861Avg Vol 1M: 5,64,70852W Range:₹0.94₹1.59
BSE
Key Ratios
Updated just now
Market Cap₹48 Cr
Current Price₹0.58
Previous Close₹0.6
High / Low (52w)₹1.59 / ₹0.94
Volume3,36,296
Avg Vol (1W)5,06,861
Avg Vol (1M)5,64,708
Stock P/E60
Book Value₹1.97
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B0.61
Debt / Equity—
50 DMA₹0.62
200 DMA₹0.66
Day change-3.33%
Price Chart
₹0.58▼ 33.33% · 1Y
₹1₹124.0L
2025-06-17
2026-06-16

20-day avg volume: 5.3L shares

Pros
  • Net profit is growing year over year.
  • Stock trades below its book value.
Cons
  • Revenue fell 78% YoY.
  • Stock trades at a high P/E of 60.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹3 Cr—
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr—
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr—
EPS00.0100.01-0.02—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹5 Cr₹23 Cr₹20 Cr₹62 Cr—
EBITDA₹1 Cr₹0 Cr₹1 Cr₹3 Cr—
Net Profit₹0 Cr₹0 Cr₹1 Cr₹2 Cr—
EPS—0.010.020.050.07
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹64 Cr₹63 Cr₹74 Cr₹80 Cr—
Total Liabilities₹0 Cr₹0 Cr₹11 Cr₹17 Cr—
Equity₹64 Cr₹63 Cr₹63 Cr₹62 Cr—
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹-8 Cr₹-10 Cr₹10 Cr₹11 Cr—
Investing₹8 Cr₹10 Cr₹-10 Cr₹-10 Cr—
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr—
Free Cash Flow₹-8 Cr₹-10 Cr₹10 Cr₹11 Cr—

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search